BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28943532)

  • 1. Relationship Between Bacteremia and Hemorrhagic Stroke in Patients With Continuous-Flow Left Ventricular Assist Device.
    Yoshioka D; Sakaniwa R; Toda K; Samura T; Saito S; Kashiyama N; Okazaki S; Domae K; Yoshikawa Y; Miyagawa S; Iso H; Sakata Y; Sawa Y
    Circ J; 2018 Jan; 82(2):448-456. PubMed ID: 28943532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Cerebral Microbleeds in Patients With Continuous-Flow Left Ventricular Assist Devices.
    Yoshioka D; Okazaki S; Toda K; Murase S; Saito S; Domae K; Miyagawa S; Yoshikawa Y; Daimon T; Sakaguchi M; Sawa Y
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28893764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors, mortality, and timing of ischemic and hemorrhagic stroke with left ventricular assist devices.
    Frontera JA; Starling R; Cho SM; Nowacki AS; Uchino K; Hussain MS; Mountis M; Moazami N
    J Heart Lung Transplant; 2017 Jun; 36(6):673-683. PubMed ID: 28110971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are blood stream infections associated with an increased risk of hemorrhagic stroke in patients with a left ventricular assist device?
    Aggarwal A; Gupta A; Kumar S; Baumblatt JA; Pauwaa S; Gallagher C; Treitman A; Pappas P; Tatooles A; Bhat G
    ASAIO J; 2012; 58(5):509-13. PubMed ID: 22820918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stroke after implantation of continuous flow left ventricular assist devices.
    Tsiouris A; Heliopoulos I; Mikroulis D; Mitsias PD
    J Card Surg; 2019 Jul; 34(7):541-548. PubMed ID: 31111542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors defining occurrence of ischemic and hemorrhagic strokes during continuous flow left ventricular assist device support.
    Tsiouris A; Heliopoulos I; Mikroulis D; Mitsias PD
    Gen Thorac Cardiovasc Surg; 2020 Apr; 68(4):319-327. PubMed ID: 31435873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent blood stream infection in patients supported with a continuous-flow left ventricular assist device is associated with an increased risk of cerebrovascular accidents.
    Trachtenberg BH; Cordero-Reyes AM; Aldeiri M; Alvarez P; Bhimaraj A; Ashrith G; Elias B; Suarez EE; Bruckner B; Loebe M; Harris RL; Zhang JY; Torre-Amione G; Estep JD
    J Card Fail; 2015 Feb; 21(2):119-25. PubMed ID: 25463739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. INTERMACS Analysis of Stroke During Support With Continuous-Flow Left Ventricular Assist Devices: Risk Factors and Outcomes.
    Acharya D; Loyaga-Rendon R; Morgan CJ; Sands KA; Pamboukian SV; Rajapreyar I; Holman WL; Kirklin JK; Tallaj JA
    JACC Heart Fail; 2017 Oct; 5(10):703-711. PubMed ID: 28958345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship Between Anticoagulation Intensity and Thrombotic or Bleeding Outcomes Among Outpatients With Continuous-Flow Left Ventricular Assist Devices.
    Nassif ME; LaRue SJ; Raymer DS; Novak E; Vader JM; Ewald GA; Gage BF
    Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27154497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and impact of ischemic and hemorrhagic stroke after left ventricular assist device implantation: A nationwide study.
    Thakkar S; Rupareliya C; Doshi R
    Indian Heart J; 2019; 71(5):422-424. PubMed ID: 32035527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Right Ventricular Assist Device Use in Patients Undergoing Continuous-Flow Left Ventricular Assist Device Implantation: Incidence and Risk Factors From the Interagency Registry for Mechanically Assisted Circulatory Support.
    Kiernan MS; Grandin EW; Brinkley M; Kapur NK; Pham DT; Ruthazer R; Rame JE; Atluri P; Birati EY; Oliveira GH; Pagani FD; Kirklin JK; Naftel D; Kormos RL; Teuteberg JJ; DeNofrio D
    Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29021348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular assist device outcomes based on flow configuration and pre-operative left ventricular dimension: An Interagency Registry for Mechanically Assisted Circulatory Support Analysis.
    Shah P; Birk S; Maltais S; Stulak J; Elmi A; Pagani FD; Cowger JA
    J Heart Lung Transplant; 2017 Jun; 36(6):640-649. PubMed ID: 28087105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stroke After Left Ventricular Assist Device Implantation: Outcomes in the Continuous-Flow Era.
    Harvey L; Holley C; Roy SS; Eckman P; Cogswell R; Liao K; John R
    Ann Thorac Surg; 2015 Aug; 100(2):535-41. PubMed ID: 26070599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational fluid dynamics analysis of surgical adjustment of left ventricular assist device implantation to minimise stroke risk.
    Osorio AF; Osorio R; Ceballos A; Tran R; Clark W; Divo EA; Argueta-Morales IR; Kassab AJ; DeCampli WM
    Comput Methods Biomech Biomed Engin; 2013; 16(6):622-38. PubMed ID: 22185643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood stream infection is associated with cerebrovascular accident in patients with left ventricular assist device: a systematic review and meta-analysis.
    Kanjanahattakij N; Horn B; Abdulhadi B; Wongjarupong N; Mezue K; Rattanawong P
    J Artif Organs; 2018 Sep; 21(3):271-277. PubMed ID: 29546615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients.
    Boyle AJ; Jorde UP; Sun B; Park SJ; Milano CA; Frazier OH; Sundareswaran KS; Farrar DJ; Russell SD;
    J Am Coll Cardiol; 2014 Mar; 63(9):880-8. PubMed ID: 24316083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of Residual Mitral Regurgitation After Continuous Flow Left Ventricular Assist Device Implantation.
    Kassis H; Cherukuri K; Agarwal R; Kanwar M; Elapavaluru S; Sokos GG; Moraca RJ; Bailey SH; Murali S; Benza RL; Raina A
    JACC Heart Fail; 2017 Feb; 5(2):81-88. PubMed ID: 28017353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
    Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National trends and outcomes in device-related thromboembolic complications and malfunction among heart transplant candidates supported with continuous-flow left ventricular assist devices in the United States.
    Wever-Pinzon O; Naka Y; Garan AR; Takeda K; Pan S; Takayama H; Mancini DM; Colombo P; Topkara VK
    J Heart Lung Transplant; 2016 Jul; 35(7):884-92. PubMed ID: 27151597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stroke while on long-term left ventricular assist device support: incidence, outcome, and predictors.
    Morgan JA; Brewer RJ; Nemeh HW; Gerlach B; Lanfear DE; Williams CT; Paone G
    ASAIO J; 2014; 60(3):284-9. PubMed ID: 24625532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.